Mario Ojeda‐Uribe

Centre Hospitalier de Mulhouse — France

Medicine · Health Sciences

22h-index2.1kcitations129works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(37), Chronic Myeloid Leukemia Treatments(19), Myeloproliferative Neoplasms: Diagnosis and Treatment(16), Lymphoma Diagnosis and Treatment(15), Hematopoietic Stem Cell Transplantation(14)

Publications125 total

Impact and effectiveness of RSV maternal immunization on infant hospitalizations in Buenos Aires: a hospital-based, multicentre, retrospective surveillance cohort study
The Lancet Regional Health - Americas·2025Open Access
Validation of the FL/IL6 score, a new dynamic cytokine-based risk-model in adults with acute myeloid leukemia, a prospective multicentre filo study.
Blood·2025Open Access
Impact and Effectiveness of Universal Respiratory Syncytial Virus Vaccination During Pregnancy on Infant Hospitalizations in Buenos Aires: A Retrospective Cohort Study
2025· 3 cited
A low lymphocyte‐to‐monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis
British Journal of Haematology·2025· 1 citedOpen Access
Enasidenib (ENA) Monotherapy in Patients with <i>IDH2</i> mutated Myelodysplastic Syndrome (MDS), the Ideal Phase 2 Study By the GFM and Emsco Groups
Blood·2024· 6 citedOpen Access
Randomized Phase 2 Trial of Lirilumab as maintenance Treatment in Acute Myeloid Leukemia: Results of the EFFIKIR Trial
2024Open Access
Dynamic Patterns of Seroprevalence and Severity of Rsv-Associated Disease in Young Children in Buenos Aires Before and after the COVID-19 Pandemic: A Multicentre Retrospective Cohort Study
SSRN Electronic Journal·2024· 1 citedOpen Access
Fms-like Tyrosine Kinase 3 Ligand Kinetic Profile Is the Strongest Factor Predicting Refractoriness after Induction and Event-Free Survival in Adults with AML: A Filo Prospective Multicentric Study
Blood·2023· 1 cited
P402: INOTUZUMAB OZOGAMICIN TREATMENT IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY PHILADELPHIA CHROMOSOME-NEGATIVE CD22-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-LIFE FRENCH STUDY
HemaSphere·2023Open Access
Predictors of acute ischemic cerebral lesions in immune-mediated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome
Journal of Neurology·2023· 4 cited
Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study
Blood Advances·2023· 21 citedOpen Access
A low lymphocyte‐to‐monocyte ratio (LMR) predicts PFS, POD24 and OS in previously untreated, high tumor burden follicular lymphoma (FL): an analysis from the RELEVANCE trial
Hematological Oncology·2023· 1 citedOpen Access
Predictors of acute ischemic cerebral lesions in immune-mediated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome
2023· 1 citedOpen Access
Uvéite postérieure : à propos d’un cas de leptospirose
Journal Français d Ophtalmologie·2023· 1 cited
Epag 2015 : A Phase II Randomized Placebo-Controlled Study to Assess the Impact on Outcome of Eltrombopag Administered to Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy. a French Innovative Leukemia Organization (FILO) Study
Blood·2022· 2 cited
Impact of the COVID-19 Epidemic on Patients with Myeloproliferative Neoplasia: The French Prospective Observational Study Covim
Blood·2022Open Access
Real Life Analysis of Brentuximab Vedotin (BV) Use As Consolidation Therapy in Patients with Hodgkin's Lymphoma (HL) with High Risk of Relapse after Autologous Stem Cell Transplantation (ASCT). a Retrospective Analysis of the EBMT Lymphoma Working Party
Blood·2022· 1 cited
Characteristics and clinical outcomes of SARS-CoV-2 infection in adult patients with acute leukemia in France
Leukemia Research·2022Open Access
Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy
Blood·2022· 33 citedOpen Access
Immune‐mediated thrombotic thrombocytopenic purpura prognosis is affected by blood pressure
Research and Practice in Thrombosis and Haemostasis·2022· 7 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Arnaud Pigneux(12), Norbert Ifrah(12), Norbert Vey(11), Mathilde Hunault(11), Christian Récher(10), Bruno Lioure(10), Marie C. Béné(10), Isabelle Luquet(9), Didier Bouscary(8), Jean‐Yves Cahn(8), Caroline Bonmati(8), Chantal Himberlin(8), Xavier Thomas(6), Éric Jourdan(6), François Provôt(5), Christiane Mousson(5), M. Hamidou(5), Paul Coppo(5), Tadeusz Robak(5), Jiřı́ Mayer(5)